Registry of patients with plasma cell disorders
- Conditions
- plasma cell disorders patientregistryplasma cell disorders
- Registration Number
- TCTR20240608004
- Lead Sponsor
- Mahidol University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
1.Aged 18 years and above
2.Both existing and newly diagnosed patients with plasma cell disorders, including monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, POEMS, light chain amyloidosis, solitary plasmacytoma, and multiple myeloma, according to the diagnostic criteria of the International Myeloma Working Group 2014
Exclusion Criteria
1.insufficient data needed for analysis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method register the plasma cell disorder patients 15 years number of plasma cell disorder patients
- Secondary Outcome Measures
Name Time Method incidence of plasma cell disorders 15 years number of plasma cell disorders both before and after malignancy,Time to progression from premalignant diagnosis to malignant Time to progression of monoclonal gammopathy of undetermined significant (MGUS) or smoldering multiple myeloma (SMM) to light chain amyloidosis or multiple myeloma (MM), Progression free survival from diagnosis to progress time to progression free survival,overall survival from diagnosis to death time of survival,influencing factors during treatment factors influencing overall survival, progression-free survival, and time to progression,Symptoms and signs during treatment Symptoms and signs of the disease during the diagnosis and relapse phases, including the causes of mortality in plasma cell disorder patients,genetic characteristics after diagnosis genetic characteristics of plasma cell disorder,cost-effectiveness during treatment cost-effectiveness of plasma cell disorders treatment in Thailand